Cognitive Dispersion is a Sensitive Marker for Early Neurodegenerative Changes and Functional Decline in Nondemented Older Adults

Overview

Journal Neuropsychology

Publisher American Psychological Association

Specialty Neurology

Date 2019 Mar 22

PMID 30896235

Citations 29

Authors

Katherine J Bangen

Alexandra J Weigand

Kelsey R Thomas

Lisa Delano-Wood

Lindsay R Clark

Joel Eppig

Madeleine L Werhane

Emily C Edmonds

Mark W Bondi

Affiliations

Soon will be listed here.

Abstract

Objective: Intraindividual cognitive variability (IIV), a measure of within-person variability across cognitive measures at a single time point, is associated with mild cognitive impairment (MCI) and Alzheimer's disease (AD). Little is known regarding brain changes underlying IIV, or the relationship between IIV and functional ability. Therefore, we investigated the association between IIV and cerebral atrophy in AD-vulnerable regions and everyday functioning in nondemented older adults.

Method: 736 Alzheimer's Disease Neuroimaging Initiative (ADNI) participants (285 cognitively normal [CN]; 451 MCI) underwent neuropsychological testing and serial MRI over 2 years. Linear mixed effects models examined the association between baseline IIV and change in entorhinal cortex thickness, hippocampal volume, and everyday functioning.

Results: Adjusting for age, sex, apolipoprotein E genotype, amyloid-β positivity, and mean level of cognitive performance, higher baseline IIV predicted faster rates of entorhinal and hippocampal atrophy, as well as functional decline. Higher IIV was associated with both entorhinal and hippocampal atrophy among MCI participants but selective vulnerability of the entorhinal cortex among CN individuals.

Conclusions: IIV was associated with more widespread medial temporal lobe (MTL) atrophy in individuals with MCI relative to CN, suggesting that IIV may be tracking advancing MTL pathologic changes across the continuum of aging, MCI, and dementia. Findings suggest that cognitive dispersion may be a sensitive marker of neurodegeneration and functional decline in nondemented older adults. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

Citing Articles

Growth-associated protein 43 is associated with faster functional decline among amyloid-positive individuals with objectively defined subtle cognitive decline and mild cognitive impairment.

Gonzalez A, Edwards L, Thomas K, Weigand A, Bordyug M, Brenner E Neuropsychology. 2025; 39(3):248-258.

PMID: 40063372 PMC: 11904934. DOI: 10.1037/neu0000981.

Cognitive variation reflects amyloid, tau, and neurodegenerative biomarkers in Alzheimer's disease.

Phang K, Tan C Geroscience. 2025; .

PMID: 39873919 DOI: 10.1007/s11357-025-01541-9.

The constrained-disorder principle defines the functions of systems in nature.

Ilan Y Front Netw Physiol. 2025; 4:1361915.

PMID: 39744508 PMC: 11688203. DOI: 10.3389/fnetp.2024.1361915.

Cognitive Intra-individual Variability in Cognitively Healthy APOE ε4 Carriers, Mild Cognitive Impairment, and Alzheimer's Disease: a Meta-analysis.

Aita S, Del Bene V, Knapp D, Demming C, Ikonomou V, Owen T Neuropsychol Rev. 2024; .

PMID: 39570562 DOI: 10.1007/s11065-024-09654-2.

Interplay of physical and recognition performance using hierarchical continuous-time dynamic modeling and a dual-task training regime in Alzheimer's patients.

Schwarck S, Voelkle M, Becke A, Busse N, Glanz W, Duzel E Alzheimers Dement (Amst). 2024; 16(3):e12629.

PMID: 39188923 PMC: 11345748. DOI: 10.1002/dad2.12629.

References

Reckess G, Varvaris M, Gordon B, Schretlen D . Within-person distributions of neuropsychological test scores as a function of dementia severity. Neuropsychology. 2013; 28(2):254-260. DOI: 10.1037/neu0000017. View

Landau S, Breault C, Joshi A, Pontecorvo M, Mathis C, Jagust W . Amyloid-β imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods. J Nucl Med. 2012; 54(1):70-7. PMC: 3747730. DOI: 10.2967/jnumed.112.109009. View

Malek-Ahmadi M, Lu S, Chan Y, Perez S, Chen K, Mufson E . Cognitive Domain Dispersion Association with Alzheimer's Disease Pathology. J Alzheimers Dis. 2017; 58(2):575-583. PMC: 6314665. DOI: 10.3233/JAD-161233. View

Petersen R, Aisen P, Beckett L, Donohue M, Gamst A, Harvey D . Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology. 2010; 74(3):201-9. PMC: 2809036. DOI: 10.1212/WNL.0b013e3181cb3e25. View

Nowrangi M, Rosenberg P, Leoutsakos J . Subtle changes in daily functioning predict conversion from normal to mild cognitive impairment or dementia: an analysis of the NACC database. Int Psychogeriatr. 2016; 28(12):2009-2018. PMC: 5628501. DOI: 10.1017/S1041610216000995. View

MacDonald S, Hultsch D, Dixon R . Performance variability is related to change in cognition: evidence from the Victoria Longitudinal Study. Psychol Aging. 2003; 18(3):510-23. DOI: 10.1037/0882-7974.18.3.510. View

Bakota L, Brandt R . Tau Biology and Tau-Directed Therapies for Alzheimer's Disease. Drugs. 2016; 76(3):301-13. PMC: 4757605. DOI: 10.1007/s40265-015-0529-0. View

Fischl B, van der Kouwe A, Destrieux C, Halgren E, Segonne F, Salat D . Automatically parcellating the human cerebral cortex. Cereb Cortex. 2003; 14(1):11-22. DOI: 10.1093/cercor/bhg087. View

Koscik R, Berman S, Clark L, Mueller K, Okonkwo O, Gleason C . Intraindividual Cognitive Variability in Middle Age Predicts Cognitive Impairment 8-10 Years Later: Results from the Wisconsin Registry for Alzheimer's Prevention. J Int Neuropsychol Soc. 2016; 22(10):1016-1025. PMC: 5147731. DOI: 10.1017/S135561771600093X. View

10.

Holtzer R, Verghese J, Wang C, Hall C, Lipton R . Within-person across-neuropsychological test variability and incident dementia. JAMA. 2008; 300(7):823-30. PMC: 2736784. DOI: 10.1001/jama.300.7.823. View

11.

Kelly A, Uddin L, Biswal B, Castellanos F, Milham M . Competition between functional brain networks mediates behavioral variability. Neuroimage. 2007; 39(1):527-37. DOI: 10.1016/j.neuroimage.2007.08.008. View

12.

Murtha S, Cismaru R, Waechter R, Chertkow H . Increased variability accompanies frontal lobe damage in dementia. J Int Neuropsychol Soc. 2002; 8(3):360-72. DOI: 10.1017/s1355617702813170. View

13.

Fischl B, Salat D, Busa E, Albert M, Dieterich M, Haselgrove C . Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002; 33(3):341-55. DOI: 10.1016/s0896-6273(02)00569-x. View

14.

Teng E, Becker B, Woo E, Knopman D, Cummings J, Lu P . Utility of the functional activities questionnaire for distinguishing mild cognitive impairment from very mild Alzheimer disease. Alzheimer Dis Assoc Disord. 2010; 24(4):348-53. PMC: 2997338. DOI: 10.1097/WAD.0b013e3181e2fc84. View

15.

Lovden M, Schmiedek F, Kennedy K, Rodrigue K, Lindenberger U, Raz N . Does variability in cognitive performance correlate with frontal brain volume?. Neuroimage. 2012; 64:209-15. PMC: 3508369. DOI: 10.1016/j.neuroimage.2012.09.039. View

16.

Gleason C, Norton D, Anderson E, Wahoske M, Washington D, Umucu E . Cognitive Variability Predicts Incident Alzheimer's Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker. J Alzheimers Dis. 2017; 61(1):79-89. PMC: 5714663. DOI: 10.3233/JAD-170498. View

17.

Edmonds E, Delano-Wood L, Clark L, Jak A, Nation D, McDonald C . Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors. Alzheimers Dement. 2014; 11(4):415-24. PMC: 4241187. DOI: 10.1016/j.jalz.2014.03.005. View

18.

Clark C, Pontecorvo M, Beach T, Bedell B, Coleman R, Doraiswamy P . Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study. Lancet Neurol. 2012; 11(8):669-78. DOI: 10.1016/S1474-4422(12)70142-4. View

19.

Joshi A, Pontecorvo M, Clark C, Carpenter A, Jennings D, Sadowsky C . Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects. J Nucl Med. 2012; 53(3):378-84. DOI: 10.2967/jnumed.111.090340. View

20.

West R, Murphy K, Armilio M, Craik F, Stuss D . Lapses of intention and performance variability reveal age-related increases in fluctuations of executive control. Brain Cogn. 2002; 49(3):402-19. DOI: 10.1006/brcg.2001.1507. View